Search results
Jun 9, 2021. We believe that the stock price of bluebird bio (NASDAQ: BLUE), a biotechnology company focused on gene therapies for severe genetic disorders and cancer, looks attractive at current ...
The biotech has had a tough time of it over the past few years; a pundit's revised take on the company won't improve that situation. HSBC : 43.97 (+0.85%) BLUE : 1.0200 (-3.77%) If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today Motley Fool - Sat Jan 27, 6:28AM CST.
Analyst Recommendations on bluebird bio, Inc. Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating. Mar. 27. MT. Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating. Mar. 27. MT. Wedbush Adjusts Bluebird Bio Price Target to $1.72 From $1.68, Maintains Neutral Rating. Mar. 26.
BLUE Stock 12 Month Forecast. $3.67. (307.87% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Bluebird Bio in the last 3 months. The average price target is $3.67 with a high forecast of $8.00 and a low forecast of $1.00. The average price target represents a 307.87% change from the last price of $0.90.
4 days ago · Billion Dollar Secret. View bluebird bio, Inc BLUE investment & stock information. Get the latest bluebird bio, Inc BLUE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
3 days ago · bluebird bio Stock Price (Quote) NASDAQ Stock Exchange > Healthcare > Biotechnology Open Broker Account $1.00 -0.0333 (-3.23%) At Close: May 21, 2024
Apr 24, 2022 · BLUE's stock price has decreased by -73.35% in the past year and price targets may not have had time to catch up. Stock Price Forecast The 10 analysts with 12-month price forecasts for bluebird bio stock have an average target of 5.67, with a low estimate of 1.02 and a high estimate of 13.
